Adrian Teo obtained his BSc (first Class) from the National University of Singapore (NUS). As an A*STAR scholar and an Honorary Cambridge Commonwealth Trust Scholar, he completed his PhD degree on stem cell biology with Ludovic Vallier at the University of Cambridge, UK. He then trained with Rohit Kulkarni at Joslin Diabetes Center, Harvard Medical School, as a Juvenile Diabetes Research Foundation (JDRF) Fellow, with a focus on pancreatic islet biology and diabetes. Teo is currently a Senior Principal Investigator at the A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and an Assistant Professor at Yong Loo Lin School of Medicine, NUS. His research involves the use of human pluripotent stem cells for disease modelling of diabetes, therapeutics development and cell therapy. He is also a cofounder of BetaLife Pte Ltd., a company focused on stem cell therapy for diabetes patients. He is a member of the Oxbridge Society of Singapore, the International Society for Stem Cell Research and an exco member and Vice-Secretary of the Stem Cell Society Singapore.
 from the National University of Singapore (NUS). As an A*STAR scholar and an Honorary Cambridge Commonwealth Trust Scholar, he completed his PhD degree on stem cell biology with Ludovic Vallier at the University of Cambridge, UK. He then trained with Rohit Kulkarni at Joslin Diabetes Center, Harvard Medical […]&picture=https://research.a-star.edu.sg/wp-content/uploads/2019/08/adrian-teo-imcb-e1733925122191.jpg)
